These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7130433)

  • 1. Enzyme studies in tardive dyskinesia. II. Familial aspects.
    Delisi LE; Jeste DV; Phelps BH; Wyatt RJ
    J Clin Psychopharmacol; 1982 Oct; 2(5):315-7. PubMed ID: 7130433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme studies in tardive dyskinesia. III. Noradrenergic hyperactivity in a subgroup of dyskinetic patients.
    Jeste DV; Linnoila M; Fordis CM; Phelps BH; Wagner RL; Wyatt RJ
    J Clin Psychopharmacol; 1982 Oct; 2(5):318-20. PubMed ID: 6752214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
    Wagner RL; Jeste DV; Phelps BH; Wyatt RD
    J Clin Psychopharmacol; 1982 Oct; 2(5):312-4. PubMed ID: 7130432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
    Markianos M; Tripodianakis J; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
    Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biochemical study of tardive dyskinesia in young male patients.
    Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ
    Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
    Xavier Vieira R; Azevedo M; Polónio P; Manso C
    Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
    Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
    J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase activity and tardive dyskinesia.
    Morgenstern H; Hafez HM; Glazer WM; Giller E; Zahner G
    Psychiatry Res; 1988 Aug; 25(2):163-71. PubMed ID: 2902653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 12. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
    Gałecki P; Pietras T; Szemraj J
    Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood MAO/DBH index and the results of the treatment of endogenous depression].
    Puzyński S; Hauptmann M; Rode A; Kalinowski A; Bidzińska E; Beresewicz M; Bidziński A
    Psychiatr Pol; 1990; 24(3):202-8. PubMed ID: 2084728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum DBH and platelet MAO in patients with depressive disorders.
    Honecker H; Fähndrich E; Coper H; Helmchen H
    Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia].
    Gałecki P; Pietras T; Florkowki A
    Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.